Meeting
2024 ASCO Genitourinary Cancers Symposium
Malignant epithelioid angiomyolipoma (eAML)/PEComa of the kidney: A genomic landscape study.
Authors
Rebecca A Sager
SUNY Upstate Medical University, Syracuse, NY
Rebecca A Sager , Michael Basin , Joseph M Jacob , Alina Basnet , Dean C. Pavlick , Douglas I. Lin , Andrea Necchi , Philippe E. Spiess , Roger Li , Ashish M. Kamat , Petros Grivas , Michael A Daneshvar , Hanan Goldberg , Mehdi Mollapour , Jeffrey S. Ross , Gennady Bratslavsky
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 451)
DOI
10.1200/JCO.2024.42.4_suppl.451
Abstract #
451
Poster Bd #
J12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with non-chromophobe RCC (nonchrRCC): Impact of FLCN genomic alteration (GA) status.
First Author: Gennady Bratslavsky
Poster
2019 ASCO Annual Meeting
Frequency of BRCA mutation in biliary tract cancer and its correlation with tumor mutational burden (TMB) and microsatellite instability (MSI).
First Author: Gilbert Spizzo
Poster
2019 ASCO Annual Meeting
Ductal (PDC), acinar (PAC) and neuroendocrine (PNC) carcinomas of the prostate: A comparative comprehensive genomic profiling (CGP) study.
First Author: Gennady Bratslavsky
Poster
2023 ASCO Annual Meeting
A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.
First Author: Elias Chandran